NASDAQ: HRTX Long Term Shareholder Notice: Investigation of Potential Wrongdoing at Heron Therapeutics, Inc.
An investigation was announced concerning potential breaches of fiduciary duties by certain directors and officers of Heron Therapeutics, Inc..
View full press release